Can chronic maxillary sinusitis cause or aggravate obstructive sleep apnea?

Can Chronic Maxillary Sinusitis Cause or Aggravate Obstructive Sleep Apnea?

Yes, chronic maxillary sinusitis (and chronic rhinosinusitis more broadly) can cause and aggravate obstructive sleep apnea through both mechanical nasal obstruction and inflammatory pathways, with recent high-quality evidence establishing a causal relationship from CRS to OSA.

Evidence for Causation

The most recent and highest quality evidence comes from a 2026 Mendelian Randomization study that definitively establishes CRS causally increases OSA risk (OR = 1.11,95% CI: 1.03-1.20, p = 0.008) 1. This genetic analysis overcomes the limitations of observational studies by demonstrating true causation rather than mere association. Importantly, the reverse direction showed no significant causal effect—OSA does not cause CRS 1.

Supporting observational data shows:

• 20% prevalence of OSA among CRS patients (95% CI: 19-21%) 1
• CRS patients have a 14% increased risk of developing OSA (OR = 1.14,95% CI: 1.08-1.20) 1
• 62% of CRS patients awaiting sinus surgery are at high risk for OSA based on validated screening 2

Mechanisms of Action

Primary Pathways

Inflammatory mechanisms appear more important than simple mechanical obstruction 3, 4. A 2024 study of 601 patients found that awake nasal resistance did not correlate with OSA presence—74.8% of patients with low nasal resistance still had OSA 3. However, CRS patients showed elevated nasal inflammatory markers (IL-6, IL-8, eosinophilic cationic protein, neutrophils) that were independent of nasal resistance 3.

The key mechanisms include:

1. Hypoxia-inducible factor (HIF) upregulation: OSA risk correlates with increased HIF-2α expression in sinonasal tissue (116.80 vs. 47.37 in high vs. low OSA risk, p < 0.05), particularly in non-eosinophilic CRS 5

2. Supraglottic inflammation: Inflammatory mediators from CRS may impair upper airway reflex mechanisms and increase airway collapsibility during sleep 3, 4

3. Systemic inflammation and oxidative stress: CRS-related inflammation extends beyond local effects through autonomic pathways, leading to intermittent hypoxia and sleep fragmentation 4

4. Sleep architecture disruption: CRS causes sleep fragmentation and lighter non-REM sleep, with some patients showing reduced REM sleep 4

Clinical Implications

Screening Recommendations

Screen all CRS patients for OSA, particularly those with:

• Age < 50 years
• Female gender
• High SNOT-22 scores (≥30)
• Symptoms of excessive daytime sleepiness 2

The STOP-BANG questionnaire is appropriate for initial screening in CRS populations 2.

Treatment Considerations

Intranasal corticosteroids are recommended for pediatric OSA with co-existing rhinitis/adenotonsillar hypertrophy (Grade B recommendation) 6. They improve mild-to-moderate OSA in children by reducing adenoid size and upper airway inflammation 6.

However, intranasal steroids as a single intervention are NOT recommended for adult OSA (Grade C recommendation) 6. One small study showed modest AHI reduction and improved nasal airflow but no significant improvements in oxygenation, sleep quality, or snoring 6.

Functional endoscopic sinus surgery (FESS) improves sleep outcomes in CRS patients 7, 8. Multiple studies demonstrate:

• Reduced AHI after surgery
• Improved subjective sleep quality scores
• Decreased excessive daytime sleepiness
• Restoration of some REM sleep 4, 8

Important Caveats

1. Nasal surgery alone cannot be recommended as primary OSA treatment (Grade C recommendation) 6. While it may reduce therapeutic CPAP pressure requirements in patients with nasal obstruction, it rarely cures OSA 6.

2. Residual OSA typically persists after CRS treatment, necessitating continued OSA management 8. The relationship is contributory, not fully causative.

3. Asthma comorbidity amplifies the burden: Patients with both CRS and asthma have worse lung function and quality of life than asthma alone, with severe CRS being an independent predictor of asthma exacerbations (OR 5.5) 9, 10.

Clinical Algorithm

For patients with chronic maxillary sinusitis:

1. Assess OSA risk using STOP-BANG or similar validated tool
2. If high OSA risk: Refer for polysomnography regardless of classic OSA symptoms
3. Optimize CRS treatment with appropriate medical therapy (intranasal corticosteroids, antibiotics if indicated)
4. Consider FESS for medically refractory CRS, which may improve both sinus disease and sleep parameters
5. Initiate OSA-specific therapy (CPAP, oral appliances) as indicated by severity—do not rely on CRS treatment alone to resolve OSA
6. Reassess sleep symptoms after CRS treatment, but maintain OSA therapy until repeat sleep study confirms improvement

The evidence clearly establishes CRS as a modifiable risk factor for OSA 1, making aggressive CRS management an important component of comprehensive OSA care, though not a replacement for standard OSA therapies.